
PLEXUS CONFIDENTIAL
FISCAL FOURTH QUARTER AND FISCAL 2026 HIGHLIGHTSOctober 28, 2026
1
PLEXUS CONFIDENTIAL
FISCAL FOURTH QUARTER AND FISCAL 2026 THEMESF26 record revenue of
$5B, with robust wins and substantial funnel expansion. Now forecasting F27 revenue growth in the mid- to upper-teens.
F26 operating margin of 6.2% exceeded our 6.0% goal. Anticipate continued operating margin expansion for F27 in pursuit of new 6.5%7.0% operating margin goal.
F26 ROIC exceeded 15% enduring goal. Forecast strong F27 ROIC performance from sustained working capital efficiency and disciplined capital spending.
OUR VISION
WE HELP CREATE THE PRODUCTS THAT BUILD A BETTER WORLD3
OUR MISSION
THE LEADER IN HIGHLY COMPLEX PRODUCTS AND DEMANDING REGULATORY ENVIRONMENTS FINANCIAL RESULTSRecord Q4F26 revenue exceeded guidance
Q4F26 revenue growth of 9% sequentially and 35% year over year
Q4F26 Non-GAAP operating margin of 6.7% and Non-GAAP EPS of $2.84 exceeded guidance
Excludes stock-based compensation expense
4
WINS AND FUNNEL HIGHLIGHTS*Strong Q4F26 wins of $290 million, with broad-based market sector contribution
Exciting new customer programs and relationships added in support of growth technologies in Aerospace/Defense, Healthcare/Life Sciences and Industrial
Record funnel of qualified manufacturing opportunities
Inclusive of sustaining services
PLEXUS CONFIDENTIAL
SUSTAINABILITY | Q4F26 HIGHLIGHTS
Honored by Eaton for Overall Supplier Excellence and GE Vernova for Lean Manufacturing Excellence
Awarded Manufacturing Business of the Year at the 2026 Scottish Borders Business Excellence Awards and earned High Commendations for both Innovation in Business and Large Business of the Year
34,821 paid Volunteer Time Off hours supported by the global Plexus team in F26. Plexusʼ Community Foundation donated $1.5 million in F26.
Reduced absolute Scope 1 and 2 emissions by 50% across global manufacturing sites versus F23 baseline
DELIVERING EXCELLENCE
CELEBRATING OUR EATON SUPPLIER EXCELLENCE AWARD
INNOVATING RESPONSIBLY FOR AND THROUGH OUR PEOPLE, OUR SOLUTIONS & OUR OPERATIONS
- BUILT ON A FOUNDATION OF TRUST & TRANSPARENCY -
FINANCIAL GUIDANCEQ1F27 revenue of $1.410 billion to $1.460 billion
Q1F27 Non-GAAP EPS of $2.46 to $2.62
Anticipate mid- to upper-teens revenue growth and non-GAAP operating margin expansion for F27
Sustained working capital efficiency
Excludes stock-based compensation expense
Represents midpoint of guidance
7
Q4F26 missed guidance on materials timing
F26 revenue growth of 23%
F27 revenue growth expected to exceed 20% on program ramps, market share gains and
broad-based end market demand strength
8
Q4F26 vs. Q3F26
- 4%
MARKET SECTOR PERFORMANCE AEROSPACE/DEFENSE
Q1F27
Expectations
Up high single digits
Q4F26 wins grew 60% year over year
Wins highlights:
New defense customer supporting combat training
Flight refueling system for defense applications
Q4F26 vs. Q3F26
+ 6%
MARKET SECTOR PERFORMANCE HEALTHCARE/LIFE SCIENCES
Q1F27
Expectations
Up low single digits
Q4F26 beat guidance on ability to support stronger customer demand
F26 revenue growth of 19%
F27 expected revenue growth of high single digits
9
Wins highlights:
New surgical robotics relationship leveraging Plexusʼ expertise in surgical technologies
Plexusʼ medical device, regulatory and regionalization expertise brings new relationship supporting cardiac defibrillation
Q4F26 vs. Q3F26
+ 17%
MARKET SECTOR PERFORMANCE INDUSTRIAL
Q4F26 beat guidance on stronger customer demand and supply chain/operational excellence
F26 revenue growth of 27%
F27 revenue growth expected to exceed 20% with strong core industrial growth and sustained robust semicap growth
10
Q1F27
Expectations
Down low single digits
Wins highlights:
New customer supporting smart grid battery energy storage system
Execution continuing to support semicap relationship expansion
11 Inclusive of sustaining services
INCOME STATEMENTQ4F25 | Q3F26 | Q4F26 Actual | Q4F26 Guidance | |
Revenue | $1.058 billion | $1.305 billion | $1.427 billion | $1.330 billion to $1.380 billion |
Gross margin | 9.9% | 10.1% | 10.2% | 10.0% to 10.3% |
Selling & administrative expense * | $51.7 million | $70.1 million | $59.7 million | $57.5 to $58.5 million |
GAAP operating margin * | 5.0% | 4.7% | 6.0% | 5.5% to 5.9% |
Non-GAAP operating margin | 5.8% | 6.3% | 6.7% | 6.1% to 6.5% |
Non-operating expense | $3.4 million | $4.8 million | $5.8 million | Approximately $6.3 million |
GAAP diluted EPS * | $1.87 | $1.58 | $2.51 | $2.18 to $2.34 |
Non-GAAP diluted EPS | $2.14 | $2.32 | $2.84 | $2.47 to $2.63 |
12
Includes stock-based compensation expense
13
CASH FLOW AND BALANCE SHEETQ4F25 | Q3F26 | Q4F26 | |
Free cash flow | $97.2 million | $0.7) million | $6.4 million |
Share repurchases | $21.5 million | $20.6 million | $21.4 million |
Cash balance | $307 million | $315 million | $281 million |
Total debt | $138 million | $275 million | $261 million |
Return on invested capital | 14.6% | 14.9% | 15.8% |
Cash cycle days | 63 days | 62 days | 62 days |
Q4F25 | Q1F26 | Q2F26 | Q3F26 | Q4F26 | |
Days in Accounts Receivable | 57 | 58 | 55 | 56 | 60 |
Days in Contract Assets | 13 | 13 | 12 | 13 | 13 |
Days in Inventory | 118 | 124 | 120 | 116 | 119 |
Days in Accounts Payable | 70 | 71 | 74 | 76 | 81 |
Days in Advanced Payments | 55 | 55 | 49 | 47 | 49 |
Net Cash Cycle Days | 63 | 69 | 64 | 62 | 62 |
14
NONGAAP OPERATING MARGIN
Increasing Non-GAAP Operating Margin Goal to 6.5%7.0%
15 Excludes stock-based compensation expense
FISCAL FIRST QUARTER 2027 GUIDANCEQ1F26 | Q4F26 | Q1F27 Guidance | |
Revenue | $1.070 billion | $1.427 billion | $1.410 billion to $1.460 billion |
GAAP diluted EPS * | $1.51 | $2.51 | $2.16 to $2.32 |
Non-GAAP diluted EPS | $1.78 | $2.84 | $2.46 to $2.62 |
Gross margin | 9.9% | 10.2% | 9.7% to 10.0% |
Selling & administrative expense * | $51.7 million | $59.7 million | $61.0 to $62.0 million |
GAAP operating margin * | 5.1% | 6.0% | 5.5% to 5.9% |
Non-GAAP operating margin | 5.8% | 6.7% | 6.0% to 6.4% |
Depreciation and amortization | $19.2 million | $19.7 million | Approximately $21 million |
Non-operating expense | $3.4 million | $5.8 million | Approximately $6.8 million |
Non-GAAP effective tax rate | 17% | 14% | 16% to 18% |
Diluted weighted average shares outstanding | 27.3 million | 27.2 million | 27.1 million |
Cash cycle days | 69 | 62 | 66 to 70 days |
16
Includes stock-based compensation expense
Q&A Thank you
17
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |

